BioVaxys
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
146 Thirtieth St Ste 100, Etobicoke, Ont...Phone Number
(740) 358-0555Website
www.biovaxys.comRevenue
<$5 MillionStock Symbol
BVAXFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioVaxys
BioVaxys stands at the forefront of biotechnological innovation, with a focus on developing advanced antigen presentation methods and treatments in oncology, infectious disease, antigen desensitization, allergy, autoimmune diseases, and other immune dysfunctions.Explore more
BioVaxys Org Chart
DB
Founder & Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioVaxys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
BioVaxys, which may be a good buyer, showed buying intent in Masked Content Topic
Check if BioVaxys has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once BioVaxys has new funding data
Click to see if BioVaxys had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BioVaxys recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioVaxys
Product Launch: Get notified when BioVaxys launches new products
Check out if BioVaxys is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BioVaxys
Compare insights from companies similar to BioVaxys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioVaxys is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioVaxys is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioVaxys.
BioVaxys financials insights
Gather financial insights about BioVaxys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Share Placement
$305K
2025
Stock/Share Issuance
$1.6M
Stock/Share Issuance
$2M
BioVaxys Tech Stack
A closer look at the technologies used by BioVaxys
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Facilities Relocation / Expansion
Partnership, Facilities Relocation/Expansion, Research & Development, Laboratory Operations, Medical Research, Clinical Operations, Manufacturing Operations, Operations
New Hire
Executive Move
Executive Moves, New Hire
BioVaxys News & Media
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 30, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an increase to its non-brokered private placement...BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 30, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an increase to its non-brokered private placement...BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, Oct. 22, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured...BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES AND GRANT OF STOCK OPTIONS
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding BioVaxys
Sign Up For FreeTo access detailed company insights
BioVaxys stands at the forefront of biotechnological innovation, with a focus on developing advanced antigen presentation methods and treatments in oncology, infectious disease, antigen desensitization, allergy, autoimmune diseases, and other immune dysfunctions.... Read More
